Funding agencies: This study was supported by a grant from the Michael J. Fox Foundation. E.B. was also supported by grants from the Agence Nationale de la Recherche, the China Science Fund, the Seventh Framework Programme (FP7 of the European Union, France Parkinson, Fondation de France, and the Cariplo Foundation.
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia
Version of Record online: 6 FEB 2013
Copyright © 2012 Movement Disorder Society
Volume 28, Issue 8, pages 1088–1096, July 2013
How to Cite
Bezard, E., Tronci, E., Pioli, E. Y., Li, Q., Porras, G., Björklund, A. and Carta, M. (2013), Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia. Mov. Disord., 28: 1088–1096. doi: 10.1002/mds.25366
Relevant conflicts of interest/financial disclosures: E.B. has an equity stake in Motac Holding Ltd. and receives consultancy payments from Motac Neuroscience Ltd. E.B., Q.L., and G.P. are employees of Motac Neuroscience Ltd.
Full financial disclosures and author roles may be found in the Acknowledgments section online.
- Issue online: 12 AUG 2013
- Version of Record online: 6 FEB 2013
- Manuscript Accepted: 21 DEC 2012
- Manuscript Revised: 19 DEC 2012
- Manuscript Received: 24 AUG 2012